Clinical trial
Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents (XL PAD SFA DES)
NCT03671655 is registered in ClinicalTrials.gov with North Texas Veterans Healthcare System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents (XL PAD SFA DES)
- Lead sponsor
- North Texas Veterans Healthcare System
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 4 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic total occlusion of artery of the extremities, peripheral vascular diseases